Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Myochrysine (2014-03-12)

Starting date:
March 12, 2014
Posting date:
March 21, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-38401

Recalled Products

Myochrysine

Reason

This product may have been exposed to temperatures outside of the recommended storage requirements. The safety and efficacy of these drugs may be impacted by the temperature excursion.

Note: only the units shipped from Canadadrugs.com to Pharmawest Pharmacy Ltd. are affected, not the entire lot.

Depth of distribution

Distributed to a pharmacy located in B.C. Canada and further distributed to end user in the United States.

Affected products

Myochrysine

DIN, NPN, DIN-HIM
DIN 01927604
Dosage form

Solution

Strength

Gold Sodium Thiomalate 50 mg/mL

Lot or serial number

1A0002

Companies
Recalling Firm
CanadaDrugs.com LP
10 Terracon Place
Winnipeg
R2J 4G7
Manitoba
CANADA
Marketing Authorization Holder
Sanofi Aventis (Canada) Inc.
2905 Louis R. Renaud Place
Laval
H7V 0A3
Quebec
CANADA